Research Paper Volume 16, Issue 2 pp 1218—1236
Development and validation of a combined cuproptosis and immunogenic cell death prognostic model for diffuse large B-cell lymphoma
Figure 8. Validation the expression of CRIRLs. (A) ANKRD10-IT1, (B) HOXB-AS1, (C) LINC00520, (D) LINC01165 expression in human B lymphoid cell line and human DLBCL cell lines. *P < 0.05; **P < 0.01; ***P < 0.001.